» Articles » PMID: 24786144

Predisposing Factors Associated with Development of Persistent Compared with Paroxysmal Atrial Fibrillation

Overview
Date 2014 May 3
PMID 24786144
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Once atrial fibrillation (AF) progresses to sustained forms, adverse outcomes increase and treatment success rates decrease. Therefore, identification of risk factors predisposing to persistence of AF may have a significant impact on AF morbidity.

Methods And Results: We prospectively examined the differential associations between traditional, lifestyle, and biomarker AF risk factors and development of paroxysmal versus nonparoxysmal AF (persistent/permanent) among 34 720 women enrolled in the Women's Health Study who were free of cardiovascular disease and AF at baseline. AF patterns were defined based on current guidelines and classified according to the most sustained form of AF within 2 years of diagnosis. During a median follow-up of 16.4 years, 690 women developed paroxysmal AF and 349 women developed nonparoxysmal AF. In multivariable time-varying competing risk models, increasing age (hazard ratio [HR] 1.11, 95% CI 1.10 to 1.13, versus HR 1.08, 1.07 to 1.09, per year), body mass index (HR 1.07, 1.05 to 1.09, versus HR 1.03, 1.02 to 1.05, per kg/m(2)), and weight (HR 1.30, 1.22 to 1.39, versus HR 1.14, 1.08 to 1.20, per 10 kg) were more strongly associated with the development of nonparoxysmal AF compared with paroxysmal AF. Hemoglobin A1c levels at baseline were directly related to the development of nonparoxysmal AF but inversely associated with paroxysmal AF in multivariable competing risk models (P for nonequal association=0.01).

Conclusions: In women without AF or CVD at baseline, increasing age, adiposity, and higher hemoglobin A1c levels were preferentially associated with the early development of nonparoxysmal AF. These data raise the hypothesis that efforts aimed at weight reduction or glycemic control may affect the proportion of the population with sustained AF.

Citing Articles

Weight reduction interventions for the management of atrial fibrillation in overweight and obese people.

Valli H, Tindale A, Butt H, Beattie C, Adasuriya G, Warraich M Cochrane Database Syst Rev. 2025; 5:CD014768.

PMID: 39908074 PMC: 11091950. DOI: 10.1002/14651858.CD014768.


Combination of Body Mass Index and Waist Circumference Burden Determines the Risk of Atrial Fibrillation.

Rhee T, Han K, Choi E, Kim B, Lee K, Choi J JACC Asia. 2025; 5(1):129-139.

PMID: 39896248 PMC: 11782094. DOI: 10.1016/j.jacasi.2024.08.021.


MicroRNAs and other biomarkers of atrial fibrillation in ischemic stroke patients.

Jansky P, Kaplan V, Sramkova T, Kolman F, Kloudova P, Benesova K Medicine (Baltimore). 2024; 103(43):e40165.

PMID: 39470526 PMC: 11521022. DOI: 10.1097/MD.0000000000040165.


A randomized controlled trial of a "Small Changes" behavioral weight loss treatment delivered in cardiac rehabilitation for patients with atrial fibrillation and obesity: study protocol for the BE-WEL in CR-AF study.

Williamson T, Rouleau C, Wilton S, Valdarchi A, Moran C, Patel S Trials. 2024; 25(1):671.

PMID: 39394158 PMC: 11468115. DOI: 10.1186/s13063-024-08527-6.


Targeting the Substrate for Atrial Fibrillation: JACC Review Topic of the Week.

McCauley M, Iacobellis G, Li N, Nattel S, Goldberger J J Am Coll Cardiol. 2024; 83(20):2015-2027.

PMID: 38749620 PMC: 11460524. DOI: 10.1016/j.jacc.2024.02.050.


References
1.
Glynn R, Rosner B . Methods to evaluate risks for composite end points and their individual components. J Clin Epidemiol. 2004; 57(2):113-22. DOI: 10.1016/j.jclinepi.2003.02.001. View

2.
Conen D, Ridker P, Everett B, Tedrow U, Rose L, Cook N . A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women. Eur Heart J. 2010; 31(14):1730-6. PMC: 2903714. DOI: 10.1093/eurheartj/ehq146. View

3.
Deo R, Katz R, Kestenbaum B, Fried L, Sarnak M, Psaty B . Impaired kidney function and atrial fibrillation in elderly subjects. J Card Fail. 2010; 16(1):55-60. PMC: 2818049. DOI: 10.1016/j.cardfail.2009.07.002. View

4.
Dublin S, French B, Glazer N, Wiggins K, Lumley T, Psaty B . Risk of new-onset atrial fibrillation in relation to body mass index. Arch Intern Med. 2006; 166(21):2322-8. DOI: 10.1001/archinte.166.21.2322. View

5.
Spiegelman D, Israel R, Bouchard C, Willett W . Absolute fat mass, percent body fat, and body-fat distribution: which is the real determinant of blood pressure and serum glucose?. Am J Clin Nutr. 1992; 55(6):1033-44. DOI: 10.1093/ajcn/55.6.1033. View